Obesity is a growing epidemic leading to world-wide public health concerns. In 1999–2000, 27.5% of men and 33.4% of women were obese. The prevalence increased to 35.5% in men and 35.8% in women by 2009–2010. Bariatric surgery is an excellent option for patients with clinically severe obesity, defined as body mass index (BMI) of greater than 40 or BMI of >35 with serious comorbid conditions.
Citation: Giuliano C, Wilhelm SM, Kale-Pradhan PB (2012) Pharmacokinetic Changes Secondary to Roux en Y Gastric Bypass. Adv Pharmacoepidem Drug Safety S1:001. doi: 10.4172/2167-1052.S1-001